Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.24 | - | - |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €96.50 | - | - |
| Davita Inc. | 2 | 0 | 0 | 0 | €128.65 | €124.89 | -2.924% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.62 | €3.70 | 129.102% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €95.50 | €124.85 | 30.731% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.75 | €17.78 | 103.191% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €23.20 | €24.18 | 4.228% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.80 | €38.99 | 22.606% |
| Bruker Corp. | 7 | 1 | 0 | 0 | €69.06 | €85.68 | 24.072% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €106.75 | €147.62 | 38.282% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €361.50 | €421.61 | 16.627% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €77.50 | €75.94 | -2.018% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €69.00 | €106.18 | 53.883% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €30.00 | €41.81 | 39.380% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €158.05 | €184.76 | 16.900% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €86.00 | €92.26 | 7.279% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €23.02 | €52.03 | 125.999% |
| Halozyme Therapeutics Inc. | 14 | 0 | 2 | 0 | €41.14 | €50.33 | 22.345% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €172.35 | €216.00 | 25.326% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €39.20 | €84.74 | 116.184% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.50 | €86.90 | 16.640% |
| United Therapeutics | 18 | 0 | 3 | 0 | €252.20 | €288.66 | 14.457% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.24 | €26.01 | 35.168% |